Global Healthcare Nanotechnology (Nanomedicine) Market by Application, Disease and Geography - Forecast to 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 17, 2019--The “Healthcare Nanotechnology (Nanomedicine) Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The primary demand of this field in medicine is in making improvements in the delivery of treatments and healthcare outcomes. Nanomedicine refers to the usage of nanoscale healthcare technology in pharmaceutical applications to make medically useful products.
Nanomedicine is a promising mode of cancer treatment. This growing field of medical research can be used to discover a better-personalized treatment for a range of diseases, including cancers. With the advantage of the properties of matter at the nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.
The need for technological advancements to enhance disease diagnosis, treatment, and prevention is the major driver for the nanomedicine market.
In the case of cancers, nanomedicine offers promising changes from the current methods of diagnosing and treating cancer. Translation of nano-based cancer therapies and diagnostics has witnessed significant progress and several new developments are in the pipeline. Along with these, multiple other factors are also driving the growth of this market in the healthcare industry.
Scope of the Report
As per the scope of the report, the healthcare nanotechnology (nanomedicine) market includes products that are nanoformulations of the existing drugs or new drugs or are nanobiomaterials.
The market is segmented by its application in the medical field, as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. The market is also segmented by its use in the treatment of diseases, like cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.
Key Market Trends
The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period
A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies.
The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimer’s disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.
Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.
North America is Expected to Hold the Largest Share in the Market
In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities.
Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role.
In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs.
In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.
The major market players are focusing on technological advancements and improvements in drug bioavailability and drug administration. Some of the major players in the market are Sanofi, Pfizer, Celgene Corporation, Luminex Corporation, and Taiwan Liposome Company.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases
4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures
4.2.3 Growing Preference for Personalized Medicines
4.3 Market Restraints
4.3.1 High Cost
4.3.2 Stringent Regulations for Commercial Introduction
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Drug Delivery
5.1.3 Active Implants
5.1.4 Diagnostic Imaging
5.1.5 Tissue Regeneration
5.1.6 Other Applications
5.2 By Disease
5.2.1 Cardiovascular Diseases
5.2.2 Oncological Diseases
5.2.3 Neurological Diseases
5.2.4 Orthopedic Diseases
5.2.5 Infectious Diseases
5.2.6 Other Diseases
5.3.1 North America
5.3.4 Middle East & Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Sanofi S.A.
6.1.2 Celegene Corporation
6.1.3 CytImmune Sciences Inc.
6.1.4 Johnson & Johnson
6.1.5 Luminex Corporation
6.1.6 Merck & Co. Inc.
6.1.8 Pfizer Inc.
6.1.9 Starpharma Holdings Limited
6.1.10 Taiwan Liposome Company Ltd.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/fhdy6b
View source version on businesswire.com:https://www.businesswire.com/news/home/20190417005637/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: TECHNOLOGY NANOTECHNOLOGY HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/17/2019 11:47 AM/DISC: 04/17/2019 11:47 AM